Manager:Research and Technical Services
PL6 8DH, Devon
Phone: **44 1752 763402
Fax: **44 1752 763431
Graham J. Sewell
Having qualified as a pharmacist in 1979 and obtained my doctorate in 1982, I held several posts combining hospital pharmacy with academia. In 1999, I moved to my current post as Professor of Clinical Pharmacy, University of Bath, where I still spend one day per week in hospital practice. My practice and research interests in oncology include: dose-banding for out-patient chemotherapy, clinical pharmacokinetics, formulation and stability of cytotoxics, circadian dosing, safe-handling (I chair the UK MARC Programme) and home (ambulatory)-chemotherapy. In this work, I am currently collaborating with colleagues in Germany, Ireland, USA, Australia, and Belgium.
My work with ISOPP began with the very first meeting in 1988 (New Zealand) and I have attended every meeting since. I chaired the ISOPP II meeting in Exeter, and was a founding member of the ISOPP Society. Currently, I am President-elect and Chair of the ISOPP Research Committee, where I have introduced travel and research awards for ISOPP members.
I am deeply concerned by the lack of progress on many issues facing our Society. ISOPP is an international fellowship of practitioners with a common interest in oncology pharmacy. Members from every country can contribute and benefit, but only if we remain united as a global organisation and avoid regional divisions. However, I recognise that we must address fears by members in some regions that their interests are not adequately represented in ISOPP. Also, we must cater for situations where global standards and guidelines are not achievable, but could be developed on a Regional basis under the ISOPP umbrella. I therefore propose the establishment of ISOPP Regional Committees (perhaps Europe/Scandinavia, North America, and "Southern Hemisphere"), where the Chair of each Committee is a full member of the ISOPP Secretariat.
ISOPP must become more transparent in its business and provide more support for its membership, particularly those where English is not their first language. It must reach out to international, governmental and non-governmental organisations to increase awareness of the issues relevant to our speciality and ensure we are involved in new developments in cancer care. As Associate Editor for Journal of Oncology Pharmacy Practice, I am aware that now we must work with our new publisher to improve both quality and quantity of material published. Finally, I would like to encourage new, younger members from different countries to take their place on ISOPP Committees. I believe I can offer commitment, open leadership, and a vision that will enable ISOPP to develop and achieve these goals.